 Chromosome Aberrations
"Chromosome Aberrations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS.
| Descriptor ID |
D002869
|
| MeSH Number(s) |
C23.550.210 G05.365.590.175
|
| Concept/Terms |
Chromosome Aberrations- Chromosome Aberrations
- Aberration, Chromosome
- Aberrations, Chromosome
- Chromosome Aberration
- Abnormalities, Chromosome
- Abnormality, Chromosome
- Chromosome Abnormality
- Chromosomal Aberrations
- Aberration, Chromosomal
- Aberrations, Chromosomal
- Chromosomal Aberration
- Cytogenetic Aberrations
- Aberration, Cytogenetic
- Aberrations, Cytogenetic
- Cytogenetic Aberration
- Cytogenetic Abnormalities
- Abnormalities, Cytogenetic
- Abnormality, Cytogenetic
- Cytogenetic Abnormality
- Abnormalities, Chromosomal
- Abnormality, Chromosomal
- Chromosomal Abnormalities
- Chromosomal Abnormality
- Chromosome Abnormalities
|
Below are MeSH descriptors whose meaning is more general than "Chromosome Aberrations".
Below are MeSH descriptors whose meaning is more specific than "Chromosome Aberrations".
This graph shows the total number of publications written about "Chromosome Aberrations" by people in this website by year, and whether "Chromosome Aberrations" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 4 | 5 | | 1981 | 5 | 1 | 6 | | 1982 | 4 | 3 | 7 | | 1983 | 5 | 0 | 5 | | 1984 | 4 | 2 | 6 | | 1985 | 3 | 2 | 5 | | 1986 | 2 | 4 | 6 | | 1987 | 2 | 2 | 4 | | 1988 | 4 | 1 | 5 | | 1989 | 6 | 1 | 7 | | 1990 | 5 | 0 | 5 | | 1991 | 1 | 0 | 1 | | 1992 | 5 | 1 | 6 | | 1993 | 2 | 0 | 2 | | 1994 | 4 | 1 | 5 | | 1995 | 4 | 6 | 10 | | 1996 | 7 | 4 | 11 | | 1997 | 2 | 2 | 4 | | 1998 | 2 | 5 | 7 | | 1999 | 4 | 0 | 4 | | 2000 | 2 | 1 | 3 | | 2001 | 3 | 1 | 4 | | 2002 | 8 | 2 | 10 | | 2003 | 5 | 7 | 12 | | 2004 | 5 | 1 | 6 | | 2005 | 1 | 3 | 4 | | 2006 | 2 | 5 | 7 | | 2007 | 6 | 4 | 10 | | 2008 | 5 | 2 | 7 | | 2009 | 5 | 4 | 9 | | 2010 | 3 | 6 | 9 | | 2011 | 1 | 5 | 6 | | 2012 | 5 | 6 | 11 | | 2013 | 3 | 4 | 7 | | 2014 | 3 | 4 | 7 | | 2015 | 1 | 0 | 1 | | 2016 | 1 | 3 | 4 | | 2017 | 1 | 3 | 4 | | 2018 | 2 | 4 | 6 | | 2019 | 2 | 2 | 4 | | 2020 | 2 | 4 | 6 | | 2021 | 0 | 2 | 2 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chromosome Aberrations" by people in Profiles.
-
Epstein-Peterson ZD, Derkach A, Geyer S, Mrózek K, Kohlschmidt J, Park JH, Rajeeve S, Stein EM, Zhang Y, Iland H, Campbell LJ, Larson RA, Poiré X, Powell BL, Stock W, Stone RM, Tallman MS. Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia. Blood Adv. 2022 Jun 14; 6(11):3433-3439.
-
Patel AA, Rojek AE, Drazer MW, Weiner H, Godley LA, Le Beau MM, Larson RA. Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy. Blood Adv. 2021 10 26; 5(20):4140-4148.
-
Weinberg OK, Arber DA. Erythroleukemia: an Update. Curr Oncol Rep. 2021 04 20; 23(6):69.
-
Arber DA, Erba HP. Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC). Am J Clin Pathol. 2020 11 04; 154(6):731-741.
-
Ambros IM, Tonini GP, Pötschger U, Gross N, Mosseri V, Beiske K, Berbegall AP, Bénard J, Bown N, Caron H, Combaret V, Couturier J, Defferrari R, Delattre O, Jeison M, Kogner P, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Valent A, Van Roy N, Villamon E, Janousek D, Pribill I, Glogova E, Attiyeh EF, Hogarty MD, Monclair TF, Holmes K, Valteau-Couanet D, Castel V, Tweddle DA, Park JR, Cohn S, Ladenstein R, Beck-Popovic M, De Bernardi B, Michon J, Pearson ADJ, Ambros PF. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group. J Clin Oncol. 2020 11 01; 38(31):3685-3697.
-
Derman BA, Jasielec J, Langerman SS, Zhang W, Jakubowiak AJ, Chiu BC. Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis. Blood Cancer J. 2020 08 07; 10(8):80.
-
Liu YJ, Ussakli C, Antic T, Liu Y, Wu Y, True L, Tretiakova MS. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling. Hum Pathol. 2020 10; 104:18-29.
-
Rogers HJ, Wang X, Xie Y, Davis AR, Thakral B, Wang SA, Borthakur G, Cantu MD, Margolskee EM, Philip JKS, Sukhanova M, Bagg A, Bueso-Ramos CE, Orazi A, Arber DA, Hsi ED, Hasserjian RP. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. Am J Hematol. 2020 07; 95(7):799-808.
-
Tsai MH, Muir AM, Wang WJ, Kang YN, Yang KC, Chao NH, Wu MF, Chang YC, Porter BE, Jansen LA, Sebire G, Deconinck N, Fan WL, Su SC, Chung WH, Almanza Fuerte EP, Mehaffey MG. Pathogenic Variants in CEP85L Cause Sporadic and Familial Posterior Predominant Lissencephaly. Neuron. 2020 04 22; 106(2):237-245.e8.
-
Chen QY, Shen S, Sun H, Wu F, Kluz T, Kibriya MG, Chen Y, Ahsan H, Costa M. PBMC gene expression profiles of female Bangladeshi adults chronically exposed to arsenic-contaminated drinking water. Environ Pollut. 2020 Apr; 259:113672.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|